Profil bibliographique

Joanna Leal

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

14Publications signalées

0Citations signalées

0Affiliations récentes

Domaines associés

Multiple Myeloma Research and TreatmentsCancer therapeutics and mechanismsChronic Lymphocytic Leukemia ResearchProtein Degradation and InhibitorsHematopoietic Stem Cell Transplantation

Publications récentes

2024 conference-abstractOpenAlex

P-244 Effects of Daratumumab(dara), Cyclophosphamide (C), Thalidomide (T) and Dexamethasone (D) Combination on Lymphocyte Populations of Transplant Eligible Newly Diagnose Multiple Myeloma Patients

Allan Santos, Herbert Santos, Joanna Leal, Juliana C. Santos et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2024 conference-abstractOpenAlex

P-210 Evaluation of IL-6, IL-1β and TNF-α Polymorphisms in Multiple Myeloma Patients

Cleverson Alves Fonseca, Edvan de Queiroz Crusoé, Allan Santos, Joanna Leal et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2024 conference-abstractOpenAlex

MM-722 Lymphocyte Profiling in Newly Diagnosed Multiple Myeloma: First-Line Treatment with Cyclophosphamide Thalidomide, Dexamethasone, and Daratumumab

Allan Santos, Mariane Santos, Joanna Leal, Herbert Santos et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2024 articleOpenAlex

Lymphocyte Profiling in Newly Diagnosed Multiple Myeloma: First-Line Treatment with Cyclophosphamide, Thalidomide, Dexamethasone, and Daratumumab

Allan Santos, Mariane Santos, Joanna Leal, Herbert Santos et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2022 articleOpenAlex

Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone for Transplant Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients: Response Rate Impacts on PFS

Edvan de Queiroz Crusoé, Joanna Leal, Juliana Andrade Santos, Herbert Santos et autres

0 citationsBlood

2021 conference-abstractOpenAlex

Progression Free Survival (PFS) Analysis of Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone: A Quadruplet Intensified Treatment for Transplant Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients

Edvan de Queiroz Crusoé, Joanna Leal, Marco Aurélio Salvino, Larissa Lucas et autres

0 citationsBlood

2021 conference-abstractOpenAlex

Evaluation of Hematopoietic Stem Cell Product As a New Site for Minimal Residual Disease By Next Generation Flow in Multiple Myeloma

Herbert Santos, Glaciano Ribeiro, Allan de souza Santos, Marcos Chaves et autres

0 citationsBlood

Accès ouvert 2021 articleOpenAlex

IMPACT OF DARATUMUMAB (DARA) ADMINISTRATION DURING TRANSPLANT- ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA (TE NDMM) INDUCTION ON STEM CELL (SC) MOBILIZATION COUNT AND POST-TRANSPLANT ENGRAFTMENT

Edvan de Queiroz Crusoé, M. Chaves, Marco Aurélio Salvino, Júlio Wilson dos Santos et autres

0 citationsHematology Transfusion and Cell Therapy

2021 conference-abstractOpenAlex

P-172: Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone: a quadruplet intensified treatment for transplant eligible newly diagnosed Multiple Myeloma (TE NDMM) patients final results

Edvan de Queiroz Crusoé, Juliana C. Santos, Joanna Leal, Herbert Santos et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2021 conference-abstractOpenAlex

P-066: Effect of Daratumumab (DARA), Cyclophosphamide (C), T Halidomide (T) and Dexamethasone (D) combination of Lymphocyte populations of transplant eligible newly diagnosed Multiple Myeloma patients

Allan Santos, Herbert Santos, Marco Aurélio Salvino, Juliana C. Santos et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2021 conference-abstractOpenAlex

P-173: Impact of Daratumumab (DARA) administration during transplant-eligible newly diagnosed Multiple Myeloma (TE NDMM) induction on stem cell (SC) mobilization count and post-transplant engraftment

Edvan Crusoé, Alessandro Moura de Almeida, Marcos Chaves, Marco Aurélio Salvino et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2020 articleOpenAlex

Preliminary Results of Daratumumab, Cyclophosphamide, Thalidomide and Dexamethasone: A Quadruplet Intensified Treatment for Newly Diagnosed Multiple Myeloma (NDMM) Transplant Eligible (TE) Patients

Edvan de Queiroz Crusoé, Marco Aurélio Salvino, Sarah Queiroz Silva, Herbert Santos et autres

0 citationsBlood

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.